Core One Labs Acquires New Path Laboratories
December 23, 2021
Core One Labs Inc. has completed the acquisition of all outstanding share capital of New Path Laboratories Inc., a British Columbia-based developer and manufacturer of natural health products and functional mushroom dietary supplements. The deal was paid in common shares of Core One and is intended to expand Core One's presence in the functional mushrooms market and add retail distribution channels to generate sales revenue.
- Buyers
- Core One Labs Inc.
- Targets
- New Path Laboratories Inc.
- Sellers
- Shareholders of New Path Laboratories Inc.
- Industry
- Food & Beverage
- Location
- British Columbia, Canada
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
System One Acquires Pathfinder, LLC
April 6, 2026
IT Services
System One announced its acquisition of Pathfinder, LLC, an independent provider of outsourced project management consulting and training for capital projects in critical infrastructure sectors. Pathfinder will operate as a System One company, with Steve Cabano, the current owner, remaining in place as President. Terms were not disclosed.
-
US BioTek Laboratories Merges With NutriPATH Pathology
March 3, 2026
Healthcare Services
US BioTek Laboratories, a Seattle-based functional laboratory, has completed a strategic merger with Australian functional pathology provider NutriPATH Pathology based in Melbourne. The combined organization expands functional pathology and diagnostic testing capabilities and extends international access for healthcare providers, while NutriPATH continues operating under its established brand in Australia.
-
NeoGenomics Acquires Pathline
April 7, 2025
Healthcare Services
NeoGenomics, Inc. (NASDAQ: NEO) has completed its acquisition of Pathline, LLC, a CLIA/CAP/NYS-certified pathology laboratory headquartered in Ramsey, New Jersey. The deal strengthens NeoGenomics' commercial presence in the Northeast United States and expands its molecular and hematology-oncology testing capabilities and access to its oncology test menu.
-
StatLab Medical Products Acquires CellPath Ltd.
June 8, 2022
Medical Devices
StatLab Medical Products, a portfolio company of Audax Private Equity and Linden Capital Partners, acquired UK-based CellPath Ltd., a manufacturer and supplier focused on the histology and cytology markets. The deal adds injection-molding manufacturing capabilities, proprietary products (including the CellNass archiving service), and an established European customer base to support StatLab's international growth.
-
Core One Labs Acquires Awakened Biosciences
February 11, 2022
Biotechnology
Core One Labs Inc. (CSE: COOL) has completed the acquisition of all outstanding share capital of Awakened Biosciences Inc., adding Awakened's provisional patents and novel synthetic psilocybin production technologies to Core One's portfolio. The deal expands Core One's R&D and manufacturing capabilities in psychedelic therapeutics and secures IP that could enable lower-cost, scalable production and potential near-term revenue from non-controlled psilocybin-based compounds.
-
Core One Labs Acquires Akome Biotech
April 29, 2021
Biotechnology
Core One Labs Inc. (CSE: COOL), a Vancouver-based biotechnology company, entered into a definitive share purchase agreement to acquire all outstanding share capital of Akome Biotech Ltd. Core One will issue 3,500,000 common shares to Akome’s shareholders as consideration; the acquisition expands Core One’s psychedelic-therapeutics R&D capabilities targeting stroke, Alzheimer’s, Parkinson’s and depression.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.